Eccogene Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Eccogene Inc.
Quantité totale PI 11
Rang # Quantité totale PI 143 587
Note d'activité PI 2,1/5.0    15
Rang # Activité PI 56 701
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

9 2
0 0
0 0
0
 
Dernier brevet 2025 - Ssao inhibitors and use thereof
Premier brevet 2020 - Ssao inhibitors and use thereof
Dernière marque 2025 - TRANDD
Première marque 2024 - EG ECCOGENE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Research and development of pharmaceutical drugs; Medical, scientific, and clinical research all ...
Invention Thyroid hormone receptor agonists and use thereof. The application relates to a compound of Form...
Invention Ssao inhibitors and use thereof. The application relates to a compound of Formula (I′) or (I): ...
2024 P/S (Based on Intent to Use) Pharmaceutical preparations for the treatment of obesity, cardiometaboli...
Invention Substituted imidazoles as glp-1 receptor agonists. The application relates to a compound of Form...
2023 Invention Thyroid hormone receptor agonists and use thereof. The application relates to a compound of Formu...
2022 Invention Ssao inhibitors and use thereof. The application relates to a compound of Formula (I′) or (I): ...
2021 Invention Substituted imidazoles as glp-1 receptor agonists. The application relates to a compound of Formu...